10x Genomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
10x Genomics, Inc. (TXG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 357.46 thousand shares for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-03.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2023-11-03
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was 56.59K shares, a 92.31% decline year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-06-30 was 27.97K shares, a 77.29% decline year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-03-31 was 272.90K shares, a 71.11% decline year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-09-30 was 735.51K shares, a 5199.82% increase year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month |
|---|---|---|---|
| 2023-09-30 | 56.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 84.55K shares derived: sum of 2 quarters · filed 2023-11-03 | 357.46K shares 10-Q · filed 2023-11-03 |
| 2023-06-30 | 27.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | 300.87K shares 10-Q · filed 2023-08-04 | |
| 2023-03-31 | 272.90K shares 10-Q · filed 2023-05-04 | ||
| 2022-09-30 | 735.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 858.66K shares derived: sum of 2 quarters · filed 2022-11-03 | 1.80M shares 10-Q · filed 2022-11-03 |
| 2022-06-30 | 123.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 1.07M shares 10-Q · filed 2022-08-09 | |
| 2022-03-31 | 944.75K shares 10-Q · filed 2022-05-05 | ||
| 2021-09-30 | 13.88K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | 58.22K shares derived: sum of 2 quarters · filed 2021-11-05 | 363.87K shares 10-Q · filed 2021-11-05 |
| 2021-06-30 | 44.34K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | 350.00K shares 10-Q · filed 2021-08-06 | |
| 2021-03-31 | 305.66K shares 10-Q · filed 2021-05-07 | ||
| 2020-09-30 | 125.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 1.11M shares derived: sum of 2 quarters · filed 2020-11-12 | 1.77M shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 983.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | 1.65M shares 10-Q · filed 2020-08-12 | |
| 2020-03-31 | 663.64K shares 10-Q · filed 2020-05-12 |